| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Unrealized gain (loss) on short-term investments | - | - | 423 | 3,948 |
| Comprehensive loss | -19,742 | -48,730 | -128,534 | -18,128 |
| Net loss per share - basic (in dollars per share) | -0.31 | -0.78 | -1.97 | -0.35 |
| Net loss per share - diluted (in dollars per share) | -0.31 | -0.78 | -1.97 | -0.35 |
| Weighted average shares used to compute basic net loss per share (in shares) | 67,652,000 | 67,050,000 | 66,404,000 | 65,538,000 |
| Weighted average shares used to compute diluted net loss per share (in shares) | 67,652,000 | 67,050,000 | 66,404,000 | 65,538,000 |
TANDEM DIABETES CARE INC (TNDM)
TANDEM DIABETES CARE INC (TNDM)